vs

Side-by-side financial comparison of RadNet, Inc. (RDNT) and Teladoc Health, Inc. (TDOC). Click either name above to swap in a different company.

Teladoc Health, Inc. is the larger business by last-quarter revenue ($642.3M vs $547.7M, roughly 1.2× RadNet, Inc.). On growth, RadNet, Inc. posted the faster year-over-year revenue change (14.8% vs 0.3%). Over the past eight quarters, RadNet, Inc.'s revenue compounded faster (12.6% CAGR vs -0.3%).

RadNet is an American radiology firm. The company operates outpatient diagnostic imaging services. Headquartered in Los Angeles, California, RadNet is the largest operator of freestanding, fixed-site diagnostic imaging centers in the United States, based on the number of locations and annual imaging revenue. As of 2025, the company owns and/or operates over 400 imaging centers across Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas.

Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company headquartered in New York, New York, United States that was founded in 2002. Primary services include telehealth, medical opinions, AI and analytics, telehealth devices and licensable platform services. In particular, Teladoc Health uses telephone and videoconferencing software as well as mobile apps to provide on-demand remote medical care.

RDNT vs TDOC — Head-to-Head

Bigger by revenue
TDOC
TDOC
1.2× larger
TDOC
$642.3M
$547.7M
RDNT
Growing faster (revenue YoY)
RDNT
RDNT
+14.5% gap
RDNT
14.8%
0.3%
TDOC
Faster 2-yr revenue CAGR
RDNT
RDNT
Annualised
RDNT
12.6%
-0.3%
TDOC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RDNT
RDNT
TDOC
TDOC
Revenue
$547.7M
$642.3M
Net Profit
$-597.0K
Gross Margin
Operating Margin
5.1%
-5.6%
Net Margin
-0.1%
Revenue YoY
14.8%
0.3%
Net Profit YoY
-111.2%
EPS (diluted)
$0.00
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RDNT
RDNT
TDOC
TDOC
Q4 25
$547.7M
$642.3M
Q3 25
$522.9M
$626.4M
Q2 25
$498.2M
$631.9M
Q1 25
$471.4M
$629.4M
Q4 24
$477.1M
$640.5M
Q3 24
$461.1M
$640.5M
Q2 24
$459.7M
$642.4M
Q1 24
$431.7M
$646.1M
Net Profit
RDNT
RDNT
TDOC
TDOC
Q4 25
$-597.0K
Q3 25
$5.4M
$-49.5M
Q2 25
$14.5M
$-32.7M
Q1 25
$-37.9M
$-93.0M
Q4 24
$5.3M
Q3 24
$3.2M
$-33.3M
Q2 24
$-3.0M
$-837.7M
Q1 24
$-2.8M
$-81.9M
Operating Margin
RDNT
RDNT
TDOC
TDOC
Q4 25
5.1%
-5.6%
Q3 25
5.2%
-8.3%
Q2 25
6.2%
-8.6%
Q1 25
-5.1%
-19.2%
Q4 24
5.1%
-7.5%
Q3 24
7.4%
-6.9%
Q2 24
7.6%
-130.9%
Q1 24
2.6%
-13.5%
Net Margin
RDNT
RDNT
TDOC
TDOC
Q4 25
-0.1%
Q3 25
1.0%
-7.9%
Q2 25
2.9%
-5.2%
Q1 25
-8.0%
-14.8%
Q4 24
1.1%
Q3 24
0.7%
-5.2%
Q2 24
-0.6%
-130.4%
Q1 24
-0.6%
-12.7%
EPS (diluted)
RDNT
RDNT
TDOC
TDOC
Q4 25
$0.00
$-0.14
Q3 25
$0.07
$-0.28
Q2 25
$0.19
$-0.19
Q1 25
$-0.51
$-0.53
Q4 24
$0.08
$-0.27
Q3 24
$0.04
$-0.19
Q2 24
$-0.04
$-4.92
Q1 24
$-0.04
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RDNT
RDNT
TDOC
TDOC
Cash + ST InvestmentsLiquidity on hand
$767.2M
$781.1M
Total DebtLower is stronger
$1.1B
Stockholders' EquityBook value
$1.1B
$1.4B
Total Assets
$3.8B
$2.9B
Debt / EquityLower = less leverage
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RDNT
RDNT
TDOC
TDOC
Q4 25
$767.2M
$781.1M
Q3 25
$804.7M
$726.2M
Q2 25
$833.2M
$679.6M
Q1 25
$717.3M
$1.2B
Q4 24
$740.0M
$1.3B
Q3 24
$748.9M
$1.2B
Q2 24
$741.7M
$1.2B
Q1 24
$527.0M
$1.1B
Total Debt
RDNT
RDNT
TDOC
TDOC
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
$1.0B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.0B
Q1 24
$834.6M
Stockholders' Equity
RDNT
RDNT
TDOC
TDOC
Q4 25
$1.1B
$1.4B
Q3 25
$1.1B
$1.4B
Q2 25
$932.3M
$1.4B
Q1 25
$898.1M
$1.4B
Q4 24
$902.3M
$1.5B
Q3 24
$895.3M
$1.5B
Q2 24
$881.0M
$1.5B
Q1 24
$873.0M
$2.3B
Total Assets
RDNT
RDNT
TDOC
TDOC
Q4 25
$3.8B
$2.9B
Q3 25
$3.7B
$2.9B
Q2 25
$3.5B
$2.9B
Q1 25
$3.3B
$3.4B
Q4 24
$3.3B
$3.5B
Q3 24
$3.3B
$3.5B
Q2 24
$3.2B
$3.5B
Q1 24
$3.0B
$4.3B
Debt / Equity
RDNT
RDNT
TDOC
TDOC
Q4 25
1.00×
Q3 25
1.04×
Q2 25
1.18×
Q1 25
1.12×
Q4 24
1.13×
Q3 24
1.14×
Q2 24
1.17×
Q1 24
0.96×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RDNT
RDNT
TDOC
TDOC
Operating Cash FlowLast quarter
$84.2M
$87.7M
Free Cash FlowOCF − Capex
$85.1M
FCF MarginFCF / Revenue
13.3%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$285.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RDNT
RDNT
TDOC
TDOC
Q4 25
$84.2M
$87.7M
Q3 25
$52.8M
$99.3M
Q2 25
$120.3M
$91.4M
Q1 25
$41.5M
$15.9M
Q4 24
$42.5M
$85.9M
Q3 24
$57.4M
$110.2M
Q2 24
$116.0M
$88.7M
Q1 24
$17.1M
$8.9M
Free Cash Flow
RDNT
RDNT
TDOC
TDOC
Q4 25
$85.1M
Q3 25
$97.0M
Q2 25
$90.2M
Q1 25
$13.2M
Q4 24
$79.8M
Q3 24
$108.6M
Q2 24
$86.8M
Q1 24
$7.8M
FCF Margin
RDNT
RDNT
TDOC
TDOC
Q4 25
13.3%
Q3 25
15.5%
Q2 25
14.3%
Q1 25
2.1%
Q4 24
12.5%
Q3 24
17.0%
Q2 24
13.5%
Q1 24
1.2%
Capex Intensity
RDNT
RDNT
TDOC
TDOC
Q4 25
0.4%
Q3 25
0.4%
Q2 25
0.2%
Q1 25
0.4%
Q4 24
1.0%
Q3 24
0.2%
Q2 24
0.3%
Q1 24
0.2%
Cash Conversion
RDNT
RDNT
TDOC
TDOC
Q4 25
Q3 25
9.75×
Q2 25
8.33×
Q1 25
Q4 24
7.96×
Q3 24
17.89×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RDNT
RDNT

Commercial Insurance1$301.0M55%
Medicare1$129.2M24%
Capitation Arrangements$31.9M6%
Health Care Other$20.4M4%
Digital Health$16.4M3%
Other$15.2M3%
Medicaid1$14.0M3%
Workers Compensation Personal Injury1$12.3M2%
Health Care Management Service$7.5M1%

TDOC
TDOC

Teladoc Health Integrated Care$409.1M64%
Better Help$233.2M36%

Related Comparisons